Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of systemic B-cell response kinetics after NeisVac-C vaccination in healthy adults
2006-001723-19Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal group C disease, sponsored by University of Bristol. Primary endpoint: Number of antibody secreting cells in blood after immunization. Started Apr 2006; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal group C disease
Beyond the preview
Go deeper on 2006-001723-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001723-19.